发信人: drugbull (赶英超美), 信区: Stock
标 题: What about ZIOP @6.5
发信站: BBS 未名空间站 (Fri Oct 6 00:04:44 2017, 美东)
Anyone is interesting it @6.5 ?
it seems a good entry point.
target 14, but I don't know how long time to wait.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to
develop, acquire and commercialize, on its own or with partners, a portfolio
of cancer therapies that address unmet medical needs. The Company is
focused on developing products in immuno-oncology that employ gene
expression, control and cell technologies to deliver cell- and viral-based
therapies for the treatment of cancer and graft-versus-host-disease. It has
developed an adenoviral vector, Ad-RTS-IL-12, which is administered intra-
tumorally under the control of the RheoSwitch Therapeutic System (RTS)
expression platform. Its initial clinical stage product candidate, which is
being developed using the immuno-oncology platform is Ad-RTS-IL-12 +
veledimex. Ad-RTS-IL-12 + veledimex uses its gene delivery system to produce
interleukin-12. As of December 31, 2016, it had completed two Phase II
studies evaluating Ad-RTS-IL-12 + veledimex, for the treatment of metastatic
melanoma and metastatic breast cancer.
※ 修改:·drugbull 於 Oct 6 00:13:51 2017 修改本文·[FROM: 128.]
※ 来源:·WWW 未名空间站 网址：mitbbs.com 移动：在应用商店搜索未名空间·[FROM: 128.]